Gastric Inhibitory Polypeptide: Clinical Trials

5 trials of Gastric Inhibitory Polypeptide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 unknown. 3 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Recruiting 1, Unknown 1
Phase 11Completed 1

Follow Gastric Inhibitory Polypeptide: new trials by email Literature Review of Gastric Inhibitory Polypeptide trials Research Report on Gastric Inhibitory Polypeptide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypothalamic GLP-1 Response in Healthy Weight and Obesity
Gastric glucose, GLP-1(7-36)NH2, Exendin(9-39)NH2 - Obesity, Normal Weight
Not applicableRecruitingUniversity of Copenhagen602026-10-012026-11-02
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
glucose-dependent insulinotropic peptide, Glucose-Dependent Insulin-Releasing Hormone[3-30], Saline Solution - Diabetes Mellitus, Type 1
Not applicableCompletedSteno Diabetes Center Copenhagen122019-02-222021-05-10
Investigating the Incretin Effect in Cystic Fibrosis
Oral Glucose Tolerance test (75g 2-hour), Modified Oral Glucose Tolerance Test (50g 4-hours), Matched isoglycemic clamp - Cystic Fibrosis
CompletedLiverpool Heart and Chest Hospital NHS Foundation Trust502013-12-012015-09-02
The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study
GIP (glucose dependent insulinotropic peptide) infusion - Adipose Tissue
Not applicableUnknownLiverpool University Hospitals NHS Foundation Trust122011-04-012011-12-21
GIP: Glucose-dependent Insulinotropic Peptide
GIP, Modified GIP, Normal Saline - Type 2 Diabetes
Phase 1CompletedNational Institute on Aging (NIA)412003-02-012013-11-28

Conditions studied

Obesity (2)  ·  Cystic Fibrosis (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Hypoglycemia (1)  ·  Insulin Resistance (1)

Sponsors

Liverpool Heart and Chest Hospital NHS Foundation Trust (1)  ·  Liverpool University Hospitals NHS Foundation Trust (1)  ·  National Institute on Aging (NIA) (1)  ·  Steno Diabetes Center Copenhagen (1)  ·  University of Copenhagen (1)

Countries

Denmark (2)  ·  United Kingdom (2)  ·  United States (1)

Top investigators

Filip K Knop, MD, PhD (1)  ·  Gareth H Jones, MBChB (1)  ·  Josephine Egan, MD (1)  ·  Sarah Byberg, MD, PhD (1)

Results publications

PMID 24712564